The trajectory of copyright's flagship drug presents a interesting case for stakeholders in the pharmaceutical sector. While initially a blockbuster success, creating billions, the intellectual property end and the https://pharma327000.alltdesign.com/sildenafil-and-the-pharmaceutical-industry-a-risky-bet-60493832